有投资者向海普瑞提问, 董秘好!请问贵司这个H1710临床批准后丸久才有临床报告出来呢?公司回答表示,您好,公司正在加快推动临床研究相关工作,新药研发具有周期长、投入大、风险高的特点,临床过程和结果存在诸多不确定性,如有重大进展,公司将及时履行信息披露义务,感谢您的关注!
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.